Results 141 to 150 of about 1,091,780 (307)

Issues and Challenges for the Romanian Insurance Market: Risk and Return Analysis [PDF]

open access: yes
Romanian insurance industry has a competitive market, having, however, a deep character of heterogeneity, which has had an impact on different financial ratios that define it.
Dan-Oliver STAICU   +1 more
core  

Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans

open access: yesArthritis &Rheumatology, EarlyView.
Objective We examine coverage of self‐administered disease‐modifying antirheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022–2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T cell costimulatory modulator, interleukin‐6 (IL ...
Youngmin Kwon   +2 more
wiley   +1 more source

TRENDS AND PROBLEMS IN THE CONTEMPORARY DEVELOPMENT OF THE INSURANCE MARKET OF RUSSIA

open access: yesНаучный вестник МГТУ ГА, 2016
The article reveals features and tendencies of development of the Russian insurance market, indicators of development of the insurance market of Russia are analyzed.
N. I. Zakharova   +2 more
doaj  

The Austrian Insurance Industry: A Structure, Conduct and Performance Analysis [PDF]

open access: yes
There exist a vast number of studies on the banking industry. However, the insurance industry remains relatively unexplored. Increasingly, Austrian insurance institutions are becoming important as financial intermediaries in the domestic market, and ...
Jedlicka, Lorenz, Jumah, Adusei
core  

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

When Can Partial Public Insurance Produce Pareto Improvements? [PDF]

open access: yes
Wilson (1977) provided the striking result that the government can always Pareto dominate a pooling equilibrium in a private insurance market with adverse selection by providing the pooling policy as a compulsory public policy and allowing individuals to
Amy Finkelstein
core  

The probationary period as a screening device: competitive markets [PDF]

open access: yes, 2006
Seminal papers about asymmetry of information in a competitive insurance market, and the monetary deductible as a screening device show that any existing equilibrium is of a separating type.
Karlsson, M., Spreeuw, J.
core  

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

The Labor Market Effects of National Health Insurance : Evidence From Taiwan [PDF]

open access: yes
This paper investigates the impacts of national health insurance on the labor market, by considering the case of Taiwan, which implemented national health insurance in March 1995.
Kamhon Kan, Yen-Ling Lin
core  

Home - About - Disclaimer - Privacy